Cargando…
Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism u...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476075/ https://www.ncbi.nlm.nih.gov/pubmed/35730361 http://dx.doi.org/10.1017/S003329172200174X |
_version_ | 1785100847985721344 |
---|---|
author | Townsend, Leigh Pillinger, Toby Selvaggi, Pierluigi Veronese, Mattia Turkheimer, Federico Howes, Oliver |
author_facet | Townsend, Leigh Pillinger, Toby Selvaggi, Pierluigi Veronese, Mattia Turkheimer, Federico Howes, Oliver |
author_sort | Townsend, Leigh |
collection | PubMed |
description | BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism using (18)FDG-PET, in schizophrenia/first-episode psychosis v. controls. Effect sizes (Hedges g) were pooled using a random-effects model. Primary measures were regional absolute and relative CMRGlu in frontal, temporal, parietal and occipital lobes, basal ganglia and thalamus. RESULTS: Thirty-six studies (1335 subjects) were included. Frontal absolute glucose metabolism (Hedge's g = −0.74 ± 0.54, p = 0.01; I(2) = 67%) and metabolism relative to whole brain (g = −0.44 ± 0.34, p = 0.01; I(2) = 55%) were lower in schizophrenia v. controls with moderate heterogeneity. Absolute frontal metabolism was lower in chronic (g = −1.18 ± 0.73) v. first-episode patients (g = −0.09 ± 0.88) and controls. Medicated patients showed frontal hypometabolism relative to controls (−1.04 ± 0.26) while metabolism in drug-free patients did not differ significantly from controls. There were no differences in parietal, temporal or occipital lobe or thalamic metabolism in schizophrenia v. controls. Excluding outliers, absolute basal ganglia metabolism was lower in schizophrenia v. controls (−0.25 ± 0.24, p = 0.049; I(2) = 5%). Studies identified reporting voxel-based morphometry measures of absolute (18)FDG uptake (eight studies) were also analysed using signed differential mapping analysis, finding lower (18)FDG uptake in the left anterior cingulate gyrus (Z = −4.143; p = 0.007) and the left inferior orbital frontal gyrus (Z = −4.239; p = 0.02) in schizophrenia. CONCLUSIONS: We report evidence for hypometabolism with large effect sizes in the frontal cortex in schizophrenia without consistent evidence for alterations in other brain regions. Our findings support the hypothesis of hypofrontality in schizophrenia. |
format | Online Article Text |
id | pubmed-10476075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104760752023-09-05 Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia Townsend, Leigh Pillinger, Toby Selvaggi, Pierluigi Veronese, Mattia Turkheimer, Federico Howes, Oliver Psychol Med Original Article BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism using (18)FDG-PET, in schizophrenia/first-episode psychosis v. controls. Effect sizes (Hedges g) were pooled using a random-effects model. Primary measures were regional absolute and relative CMRGlu in frontal, temporal, parietal and occipital lobes, basal ganglia and thalamus. RESULTS: Thirty-six studies (1335 subjects) were included. Frontal absolute glucose metabolism (Hedge's g = −0.74 ± 0.54, p = 0.01; I(2) = 67%) and metabolism relative to whole brain (g = −0.44 ± 0.34, p = 0.01; I(2) = 55%) were lower in schizophrenia v. controls with moderate heterogeneity. Absolute frontal metabolism was lower in chronic (g = −1.18 ± 0.73) v. first-episode patients (g = −0.09 ± 0.88) and controls. Medicated patients showed frontal hypometabolism relative to controls (−1.04 ± 0.26) while metabolism in drug-free patients did not differ significantly from controls. There were no differences in parietal, temporal or occipital lobe or thalamic metabolism in schizophrenia v. controls. Excluding outliers, absolute basal ganglia metabolism was lower in schizophrenia v. controls (−0.25 ± 0.24, p = 0.049; I(2) = 5%). Studies identified reporting voxel-based morphometry measures of absolute (18)FDG uptake (eight studies) were also analysed using signed differential mapping analysis, finding lower (18)FDG uptake in the left anterior cingulate gyrus (Z = −4.143; p = 0.007) and the left inferior orbital frontal gyrus (Z = −4.239; p = 0.02) in schizophrenia. CONCLUSIONS: We report evidence for hypometabolism with large effect sizes in the frontal cortex in schizophrenia without consistent evidence for alterations in other brain regions. Our findings support the hypothesis of hypofrontality in schizophrenia. Cambridge University Press 2023-08 2022-06-22 /pmc/articles/PMC10476075/ /pubmed/35730361 http://dx.doi.org/10.1017/S003329172200174X Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Townsend, Leigh Pillinger, Toby Selvaggi, Pierluigi Veronese, Mattia Turkheimer, Federico Howes, Oliver Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title | Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title_full | Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title_fullStr | Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title_full_unstemmed | Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title_short | Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia |
title_sort | brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)fdg-pet studies in schizophrenia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476075/ https://www.ncbi.nlm.nih.gov/pubmed/35730361 http://dx.doi.org/10.1017/S003329172200174X |
work_keys_str_mv | AT townsendleigh brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia AT pillingertoby brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia AT selvaggipierluigi brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia AT veronesemattia brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia AT turkheimerfederico brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia AT howesoliver brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia |